SMS Pharma updates against USFDA statement on Ranitidine Medical Dialogues Bureau13 April 2020 9:01 AM GMTIndia: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the m...
USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market Medical Dialogues Bureau6 April 2020 3:45 AM GMTThe U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 4:15 AM GMTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported c...
Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA Medical Dialogues Bureau4 Nov 2019 11:01 AM GMTNew Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA Medical Dialogues Bureau2 Nov 2019 4:00 AM GMTZantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible N...
GSK Pharma reports Q2 profit at Rs 503 crore Medical Dialogues Bureau1 Nov 2019 3:45 AM GMTGSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation (EB...
Drug Alert: CDSCO declares 28 samples including Soframycin, Ranitidine as sub-standard in quality; Details Farhat Nasim24 Oct 2019 8:52 AM GMTNew Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 28 drugs made by certain...
Dr Reddys recalls Ranitidine products in US over cancer-causing impurity Medical Dialogues Bureau24 Oct 2019 4:00 AM GMTThis recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr Re...
No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA Medical Dialogues Bureau24 Oct 2019 3:50 AM GMTEarly tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure Medical Dialogues Bureau9 Oct 2019 4:00 AM GMTGSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the Medici...
Strides Pharma suspends sale of Ranitidine tab in US Medical Dialogues Bureau27 Sep 2019 4:26 AM GMTNew Delhi: Strides Pharma Science on Friday suspended the sale of Ranitidine tablets after it received an information request from the US health...
CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers Farhat Nasim25 Sep 2019 7:49 AM GMTNew Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
